Cellosaurus YH-13 (CVCL_1795)

Cell line name YH-13
Synonyms YH
Accession CVCL_1795
Resource Identification Initiative To cite this cell line use: YH-13 (RRID:CVCL_1795)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Disease Glioblastoma (NCIt: C3058)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; JCRB

Markers:
AmelogeninX
CSF1PO10
D13S3179,12
D16S53912
D5S81810,12
D7S8208,12
TH018
TPOX8
vWA18
Publications

PubMed=8145054; DOI=10.1007/BF01050213
Izumu I., Mineura K., Watanabe K., Kowada M.
Characterization and chemosensitivity of two cell lines derived from human glioblastomas.
J. Neurooncol. 17:111-121(1993)

PubMed=7947440
Izumi I., Mineura K., Watanabe K., Kowada M.
Establishment of the two glioma cell lines: YH and AM.
Hum. Cell 7:101-105(1994)

PubMed=16232199; DOI=10.1111/j.1349-7006.2005.00099.x
Saigusa K., Hashimoto N., Tsuda H., Yokoi S., Maruno M., Yoshimine T., Aoyagi M., Ohno K., Imoto I., Inazawa J.
Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas.
Cancer Sci. 96:676-683(2005)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections IFO; IFO50493
Cell line databases/resources CCLE; YH13_CENTRAL_NERVOUS_SYSTEM
CGH-DB; 158-1
Cosmic-CLP; 909905
GDSC; 909905
LINCS_LDP; LCL-1392
Biological sample resources BioSample; SAMN03472800
Chemistry resources ChEMBL-Cells; CHEMBL3308223
ChEMBL-Targets; CHEMBL2366164
Gene expression databases GEO; GSM887747
GEO; GSM888842
GEO; GSM1670585
Polymorphism and mutation databases Cosmic; 687591
Cosmic; 909905
Cosmic; 2367556